Search

Search Constraints

You searched for: Author/Creator Hébuterne, Xavier

Search Results

2. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. Issue 10090 (8th July 2017)

3. Assessment of D-Dimers for the Early Prediction of Complications in Acute Pancreatitis. Issue 7 (August 2016)

4. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study. Issue 10 (18th September 2020)

5. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study. Issue 10 (27th February 2020)

6. Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD. Issue 7 (8th October 2014)

7. Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial. (December 2020)

8. Corrigendum to "ESPEN guideline: Clinical nutrition in inflammatory bowel disease" [Clinical Nutrition 36 (2017) 321–347]. Issue 3 (June 2019)

9. Corrigendum to 'ESPEN guideline: Clinical nutrition in inflammatory bowel disease' [Clinical Nutrition 36 (2) (2016) 321–347]. Issue 3 (June 2019)

10. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Issue 10114 (23rd December 2017)